Abstract 6602: Venetoclax enhances radiation-induced anticancer immunity in breast cancer.
Emma Guilbaud, Ai Sato, Lorenzo Galluzzi.
Abstract Estrogen receptor-positive (ER+) breast cancer (BC) lesions are poorly infiltrated by lymphocytes (immunologically "cold") and are therefore insensitive to immune checkpoint inhibitors (ICIs). Radiation therapy (RT) represents a clinically promising partner for ICIs, as RT converts immunologically "cold" ER+ BC into …
us (code pays fourni par la source)
0 citations
Cancer Research